 | Up a level |
Lucijanić, Marko and Skelin, Marko (2019) Platelet counts and risk of major bleeding with ibrutinib. Clinical Lymphoma Myeloma and Leukemia, 19 (7). e399. ISSN 2152-2650
Pejša, Vlatko and Lucijanić, Marko and Jonjić, Željko and Prka, Željko and Vukorepa, Gorana (2019) Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia. Annals of Hematology, 98 (6). pp. 1509-1510. ISSN 0939-5555
Lucijanić, Marko and Prka, Željko and Jakšić, Ozren and Mitrović, Zdravko and Vrkljan, Anamarija and Pejša, Vlatko (2019) Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortality. American Journal of Hematology, 94 (2). E42-E43. ISSN 0361-8609
Lucijanić, Marko and Kušec, Rajko (2019) Could haemochromatosis ( HFE ) gene mutations affect response to iron chelation in myelodysplastic syndrome? British Journal of Haematology, 186 (4). pp. 640-641. ISSN 0007-1048
Madir, Anita and Božin, Tonći and Mikolašević, Ivana and Milić, Sandra and Štimac, Davor and Mijić, Maja and Filipec Kanižaj, Tajana and Biloglav, Zrinka and Lucijanić, Marko and Lucijanić, Iva and Grgurević, Ivica (2019) Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study. Croatian Medical Journal, 60 (6). pp. 494-502. ISSN 0353-9504
Lucijanić, Marko and Čičić, David and Štoos-Veić, Tajana and Pejša, Vlatko and Rahelić, Dario and Lucijanić, Tomo and Vasilj, Tamara and Ivić, Marija and Sedinić, Martina and Kušec, Rajko (2018) Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients. Blood Cells, Molecules, and Diseases, 72. pp. 14-16. ISSN 1079-9796
Lucijanić, Marko and Livun, Ana and Tupek, Katarina Marija and Štoos-Veić, Tajana and Pejša, Vlatko and Kušec, Rajko (2018) Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis. Annals of Hematology, 97 (7). pp. 1293-1294. ISSN 0939-5555
Lucijanić, Marko and Prka, Željko and Pejša, Vlatko and Štoos-Veić, Tajana and Lucijanić, Jelena and Kušec, Rajko (2018) Prognostic implications of low transferrin saturation in patients with primary myelofibrosis. Leukemia Research, 66. pp. 89-95. ISSN 0145-2126
Lucijanić, Marko and Veletić, Ivo and Rahelić, Dario and Pejša, Vlatko and Čičić, David and Skelin, Marko and Livun, Ana and Tupek, Katarina Marija and Štoos-Veić, Tajana and Lucijanić, Tomo and Magličić, Ana and Kušec, Rajko (2018) Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis. Wiener klinische Wochenschrift, 130 (3-4). pp. 126-133. ISSN 0043-5325
Lucijanić, Marko and Mitrović, Zdravko and Čičić, David and Prka, Željko and Pejša, Vlatko and Livun, Ana and Štoos-Veić, Tajana and Romić, Željko and Živković, Marcela and Lucijanić, Iva and Fabris, Zrinka and Kušec, Rajko (2018) Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis. International Journal of Hematology, 107 (2). pp. 166-172. ISSN 0925-5710
Lucijanić, Marko (2017) Analiza gena i proteina signalnih puteva Wnt i Sonic Hedgehog u primarnoj i sekundarnoj mijelofibrozi [Analysis of genes and proteins of WNT and Sonic Hedgehog signaling pathways in primary and secondary myelofibrosis]. PhD thesis, Sveučilište u Zagrebu.
Pejša, Vlatko and Prka, Željko and Lucijanić, Marko and Mitrović, Zdravko and Piršić, Mario and Jakšić, Ozren and Ajduković, Radmila and Kušec, Rajko (2017) Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients. Croatian Medical Journal, 58 (1). pp. 40-48. ISSN 0353-9504
Lucijanić, Marko and Livun, Ana and Tomasović-Lončarić, Čedna and Štoos-Veić, Tajana and Pejša, Vlatko and Jakšić, Ozren and Prka, Željko and Kušec, Rajko (2016) Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis. Clinical Lymphoma Myeloma and Leukemia, 16 (9). pp. 523-256. ISSN 2152-2650
Lucijanić, Marko and Pejša, Vlatko and Mitrović, Zdravko and Štoos-Veić, Tajana and Livun, Ana and Jakšić, Ozren and Vasilj, Tamara and Piršić, Mario and Hariš, Višnja and Prka, Željko and Kušec, Rajko (2016) Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome. Hematology, 21 (3). pp. 170-174. ISSN 1024-5332
Lucijanić, Marko and Pejša, Vlatko and Jakšić, Ozren and Mitrović, Zdravko and Tomasović-Lončarić, Čedna and Štoos-Veić, Tajana and Prka, Željko and Piršić, Mario and Hariš, Višnja and Vasilj, Tamara and Kušec, Rajko (2016) The degree of anisocytosis predicts survival in patients with primary myelofibrosis. Acta Haematologica, 136 (2). pp. 98-100. ISSN 0001-5792
Lucijanić, Marko and Lasan-Trčić, Ružica and Kušec, Rajko and Pejša, Vlatko and Štoos-Veić, Tajana and Jakšić, Ozren (2015) Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia. Annals of Hematology, 94 (9). pp. 1617-1619. ISSN 0939-5555
